Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.972 |
36 |
1
|
1996 |
2019 |
Neoplastic Syndromes, Hereditary
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms
|
Neoplastic Process
|
88
|
6387
|
0.100 |
None |
1.000 |
28 |
105
|
2003 |
2017 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
0.875 |
16 |
2
|
2005 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
0.867 |
15 |
2
|
2005 |
2019 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.450 |
None |
1.000 |
5 |
2
|
2004 |
2008 |
Hereditary Nonpolyposis Colorectal Neoplasms
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases; Neoplasms; Nutritional and Metabolic Diseases
|
Neoplastic Process
|
40
|
875
|
0.300 |
limited |
1.000 |
4 |
|
2001 |
2016 |
Precancerous Conditions
|
group |
Neoplasms
|
Neoplastic Process
|
471
|
18
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Malignant neoplasm of fallopian tube
|
group |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
10
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.060 |
None |
1.000 |
6 |
|
2003 |
2018 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2020 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.020 |
None |
1.000 |
2 |
|
2007 |
2008 |
Tumor Initiation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
533
|
8
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2017 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.020 |
None |
1.000 |
2 |
|
2007 |
2018 |
Anoxia
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
287
|
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Cachexia
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
273
|
11
|
0.200 |
None |
1.000 |
1 |
|
2006 |
2006 |
Abnormality of the fallopian tube
|
phenotype |
|
Anatomical Abnormality
|
22
|
|
0.100 |
None |
|
0 |
|
|
|
Somatic mutation
|
phenotype |
|
Cell or Molecular Dysfunction
|
151
|
|
0.100 |
None |
|
0 |
|
|
|
Triple-Negative Breast Cancer Finding
|
phenotype |
|
Finding
|
1
|
2
|
0.100 |
None |
|
0 |
2
|
|
|
BREAST CANCER, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
11
|
24
|
0.100 |
None |
|
0 |
1
|
|
|
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
1.000 |
limited |
0.896 |
67 |
74
|
1996 |
2020 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.500 |
None |
0.860 |
50 |
8
|
1996 |
2020 |
Malignant neoplasm of ovary
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2563
|
315
|
0.100 |
None |
0.833 |
18 |
1
|
2002 |
2019 |
Neuroblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2509
|
386
|
0.500 |
None |
1.000 |
16 |
17
|
2009 |
2019 |
Breast Cancer, Familial
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
183
|
91
|
0.350 |
definitive |
0.938 |
16 |
4
|
2001 |
2019 |
ovarian neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2542
|
757
|
0.200 |
None |
0.875 |
16 |
2
|
1998 |
2019 |